Nasdaq Stockholm AB: Cline Scientific AB receives observation status (284/23)

Today, May 22, 2023, Cline Scientific AB (the "Company") disclosed a press
release with information that the Company cannot assure that it has working
capital for three months. 

The rules of Nasdaq First North Growth Market state that an issuer can be given
observation status if there is material adverse uncertainty in respect of the
issuer's financial position. 

With reference to the above, Nasdaq Stockholm AB decides that the shares (CLINE
B, ISIN code SE0006758231, order book ID 226724) in Cline Scientific AB shall
be given observation status. 

For further information about this exchange notice please contact Enforcement &
Investigations, telephone [phone].